ABSTRACT
Ghrelin and the corticotropin-releasing factor (CRF) family are known regulators of cellular metabolism and energy balance. We previously demonstrated that myoblast glucose metabolism is regulated by ghrelin and that this effect is mediated by CRF receptor type 2 (CRF-R2). Here we explored the effect of des-acyl ghrelin, the major circulating isoform of ghrelin, on cellular metabolism in mouse myoblast C2C12 cells, and examined whether CRF family receptors mediate its metabolic effects in muscle cells. C2C12 cells were exposed to des-acyl ghrelin with or without the CRF-R1- and CRF-R2-specific antagonists antalarmin or antisauvagine-30, respectively. Des-acyl ghrelin reduced glucose uptake and expression of the glucose transporter GLUT4, but induced retinol-binding protein 4 (RBP4) expression. Antalarmin and antisauvagine-30 inhibited the induction of glucose uptake by des-acyl ghrelin and its effect on GLUT4 and RBP4 expression. Moreover, treating C2C12 cells with des-acyl ghrelin resulted in cAMP activation in response to the CRF-R1-specific ligand stressin, and the CRF-R2-specific ligand Ucn3. Furthermore, des-acyl ghrelin reduced the expression of uncoupling proteins UCP2 and UCP3. Adding antalarmin or antisauvagine-30 to the medium reversed this effect. Finally, des-acyl ghrelin elevated lipid content and acetyl-CoA carboxylase expression in C2C12 cells. Our results suggest that during food deprivation, des-acyl ghrelin signals the muscle cells that glucose levels are low and that they should switch to fatty acids for their metabolic fuel.
Subject(s)
Ghrelin/pharmacology , Glucose/metabolism , Lipid Metabolism/drug effects , Myoblasts/drug effects , Receptors, Corticotropin-Releasing Hormone/metabolism , Animals , Cell Line , Mice , Myoblasts/metabolismABSTRACT
Successful implantation is associated with a unique spatial pattern of vascular remodeling, characterized by profound peripheral neovascularization surrounding a periembryo avascular niche. We hypothesized that hyaluronan controls the formation of this distinctive vascular pattern encompassing the embryo. This hypothesis was evaluated by genetic modification of hyaluronan metabolism, specifically targeted to embryonic trophoblast cells. The outcome of altered hyaluronan deposition on uterine vascular remodeling and postimplantation development were analyzed by MRI, detailed histological examinations, and RNA sequencing of uterine NK cells. Our experiments revealed that disruption of hyaluronan synthesis, as well as its increased cleavage at the embryonic niche, impaired implantation by induction of decidual vascular permeability, defective vascular sinus folds formation, breach of the maternal-embryo barrier, elevated MMP-9 expression, and interrupted uterine NK cell recruitment and function. Conversely, enhanced deposition of hyaluronan resulted in the expansion of the maternal-embryo barrier and increased diffusion distance, leading to compromised implantation. The deposition of hyaluronan at the embryonic niche is regulated by progesterone-progesterone receptor signaling. These results demonstrate a pivotal role for hyaluronan in successful pregnancy by fine-tuning the periembryo avascular niche and maternal vascular morphogenesis.
Subject(s)
Decidua/blood supply , Embryo Implantation , Embryo, Mammalian/physiology , Hyaluronic Acid/pharmacology , Killer Cells, Natural/physiology , Neovascularization, Physiologic/drug effects , Uterus/physiology , Animals , Cell Differentiation , Decidua/drug effects , Decidua/metabolism , Embryo, Mammalian/cytology , Embryo, Mammalian/drug effects , Female , Killer Cells, Natural/cytology , Killer Cells, Natural/drug effects , Male , Maternal-Fetal Exchange , Mice , Mice, Inbred C57BL , Pregnancy , Signal Transduction , Trophoblasts/cytology , Trophoblasts/drug effects , Trophoblasts/physiology , Uterus/cytology , Uterus/drug effects , Vascular Remodeling , Viscosupplements/pharmacologyABSTRACT
Each follicle represents the basic functional unit of the ovary. From its very initial stage of development, the follicle consists of an oocyte surrounded by somatic cells. The oocyte grows and matures to become fertilizable and the somatic cells proliferate and differentiate into the major suppliers of steroid sex hormones as well as generators of other local regulators. The process by which a follicle forms, proceeds through several growing stages, develops to eventually release the mature oocyte, and turns into a corpus luteum (CL) is known as "folliculogenesis". The task of this review is to define the different stages of folliculogenesis culminating at ovulation and CL formation, and to summarize the most recent information regarding the newly identified factors that regulate the specific stages of this highly intricated process. This information comprises of either novel regulators involved in ovarian biology, such as Ube2i, Phoenixin/GPR73, C1QTNF, and α-SNAP, or recently identified members of signaling pathways previously reported in this context, namely PKB/Akt, HIPPO, and Notch.
Subject(s)
Gonadal Steroid Hormones/metabolism , Oogenesis , Ovarian Follicle/cytology , Ovulation , Signal Transduction , Animals , Female , Humans , Ovarian Follicle/metabolismABSTRACT
This research paper addresses the hypothesis that intensive cooling management during the summer improves the secretion of metabolic hormones in dairy cows. To test this hypothesis, we characterized the effect of different cooling managements on the different ghrelin isoforms and leptin secretion of 20 Israeli-Holstein dairy cows during 5 weeks during heat stress. The cows were divided into two groups: one was exposed to 5 cooling sessions per day (5 CS) and the other to 8 cooling sessions per day (8 CS). Blood was collected and leptin and ghrelin isoforms level were radioimmunoassayed. Analysis of the interaction between coolings and the week of the experiment showed that the 8 CS group consumed more food and produced more milk, although neither difference was statistically significant. In addition, the 8 CS group exhibited higher blood levels of acyl-ghrelin and leptin as compared to the 5 CS group. Conversely, the blood levels of total ghrelin were lower in the cows exposed to 8 CS as compared to cows from the 5 CS treatment. Furthermore, a significant correlation was found only between total ghrelin levels and the weeks, but not with other parameters examined. We further compared digestibility as well as stress parameters between the groups. We found that the 8 CS group cows ruminated and lay down more hours during a day and simultaneously had better activity time. No significant difference was detected between groups in milk yield and digestibility parameters. Our results suggest that intensive cooling management during the hot season influences the levels of metabolic hormones in the circulation and helps to mitigate the detrimental effect of heat stress on dairy cow welfare and production.
Subject(s)
Cattle Diseases/prevention & control , Dairying/methods , Eating , Ghrelin/blood , Leptin/blood , Animals , Cattle , Cattle Diseases/blood , Cattle Diseases/metabolism , Cattle Diseases/physiopathology , Eating/physiology , Female , Heat-Shock Response/physiologyABSTRACT
Resumption of meiosis in mammalian oocytes, defined as oocyte maturation, is stimulated by luteinizing hormone (LH). Fully grown oocytes can also mature spontaneously, upon their release from the ovarian follicle. However, growing oocytes fail to resume meiosis in vitro and the mechanism underlying their meiotic incompetence is unknown. It is commonly accepted that a drop in intraoocyte cyclic guanosine monophosphate (cGMP) resulting in the elevated activity of the oocyte-specific PDE3A leads to a decrease in cAMP content, essential for reinitiation of meiosis. We explored the regulation of these cyclic nucleotides and their degrading PDE3A in growing oocytes. Our research addressed the LH-induced rather than spontaneous oocyte maturation. We examined 16-21 as compared to 25-day-old, PMSG-primed rats, treated with the LH analog, hCG. The effect of LH was also examined ex vivo, in isolated ovarian follicles. We found that hCG failed to induce oocyte maturation and ovulation in the younger animals and that ovulation-associated genes were not upregulated in response to this gonadotropin. Furthemore, the drop of intraoocyte cGMP and cAMP observed in fully grown oocytes upon exposure of the ovary to LH, was not detected in growing oocytes. Interestingly, whereas the global expression of PDE3A in growing and fully grown oocytes is similar, a significantly lower activity of this enzyme was determined in growing oocytes. Our findings show that meiotic incompetence is associated with a relatively high oocyte cGMP concentration and a low activity of PDE3A, which in follicle-enclosed oocytes may represent the failure of the somatic follicle cells to respond to LH.
Subject(s)
Cyclic GMP/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 3/metabolism , Meiosis/drug effects , Oocytes/metabolism , Animals , Chorionic Gonadotropin/pharmacology , Cyclic AMP/metabolism , Female , Follicle Stimulating Hormone/analogs & derivatives , Gonadotropins, Equine/pharmacology , Luteinizing Hormone/analogs & derivatives , Oogenesis/drug effects , Ovarian Follicle/metabolism , Ovulation/drug effects , Rats , Rats, WistarABSTRACT
OBJECTIVE: The early embryo implantation is characterized by enhanced uterine vascular permeability at the site of blastocyst attachment, followed by extracellular-matrix remodeling and angiogenesis. Two TG (transglutaminase) isoenzymes, TG2 (tissue TG) and FXIII (factor XIII), catalyze covalent cross-linking of the extracellular-matrix. However, their specific role during embryo implantation is not fully understood. Approach and Results: For mapping the distribution as well as the enzymatic activities of TG2 and FXIII towards blood-borne and resident extracellular-matrix substrates, we synthetized selective and specific low molecular weight substrate analogs for each of the isoenzymes. The implantation sites were challenged by genetically modifying the trophoblast cells in the outer layer of blastocysts, to either overexpress or deplete TG2 or FXIII, and the angiogenic response was studied by dynamic contrast-enhanced-magnetic resonance imaging. Dynamic contrast-enhanced-magnetic resonance imaging revealed a decrease in the permeability of decidual vasculature surrounding embryos in which FXIII were overexpressed in trophoblast cell. Reduction in decidual blood volume fraction was demonstrated when either FXIII or TG2 were overexpressed in embryonic trophoblast cell and was elevated when trophoblast cell was depleted of FXIII. These results were corroborated by histological analysis. CONCLUSIONS: In this study, we report on the isoenzyme-specific roles of TG2 and FXIII during the early days of mouse pregnancy and further reveal their involvement in decidual angiogenesis. Our results reveal an important magnetic resonance imaging-detectable function of embryo-derived TG2 and FXIII on regulating maternal angiogenesis during embryo implantation in mice.Visual Overview: An online visual overview is available for this article.
Subject(s)
Embryo Implantation/physiology , Factor XIII/physiology , GTP-Binding Proteins/physiology , Magnetic Resonance Imaging/methods , Neovascularization, Physiologic/physiology , Transglutaminases/physiology , Animals , Female , Fibrinogen/physiology , Mice , Pregnancy , Protein Glutamine gamma Glutamyltransferase 2ABSTRACT
Cripto-1 (TDGF1) is a multifunctional signaling factor that stimulates cellular effects, including proliferation, migration, survival, epithelial-to-mesenchymal transition, and angiogenesis, to regulate embryogenesis, tissue homeostasis, and tumorigenesis. Those cell behaviors are also associated with implantation of the embryo into the uterine wall, and this led us to investigate the role of embryo-derived Cripto in embryo attachment and implantation. In this study, we show that Cripto and its signaling mediator GRP78 are uniquely localized to embryo implantation sites. We knocked down Cripto expression specifically in trophoblast cells and found that this resulted in a corresponding decrease in the levels of its downstream signaling mediators, phosphorylated (phospho-)SMAD2, phospho-SRC, phospho-extracellular signal-regulated kinase, and phospho-AKT, which are also known mediators of embryo implantation. We then transplanted Cripto knockdown and control embryos into uteri of pseudopregnant female mice and found that embryos with Cripto-depleted trophoblast cells had dramatically impaired capacity to attach to the uterine wall when compared with controls. This loss of appropriate embryo attachment following Cripto knockdown in trophoblast cells was associated with abnormally enlarged implantation sites that were almost completely devoid of microvessels. A role for Cripto in embryo implantation was further supported by our demonstration that attachment of trophoblast-derived spheroids to endometrial cells in vitro was stimulated by Cripto treatment and diminished by treatment with either of two mechanistically distinct Cripto blocking agents. Collectively, our findings identify Cripto as a novel and critical embryo attachment factor and suggest that modulation of Cripto signaling may have significant therapeutic potential for the treatment of infertility and other related disorders.
Subject(s)
Embryo Implantation/physiology , Endometrium/metabolism , Epidermal Growth Factor/metabolism , Membrane Glycoproteins/metabolism , Neoplasm Proteins/metabolism , Trophoblasts/metabolism , Animals , Cell Line , Endometrium/blood supply , Endoplasmic Reticulum Chaperone BiP , Epidermal Growth Factor/genetics , Female , Gene Knockdown Techniques , Humans , Membrane Glycoproteins/genetics , Mice , Neoplasm Proteins/genetics , Signal Transduction/physiologyABSTRACT
BACKGROUND: Forkhead Transcription Factor L2 (FOXL2) is a member of the forkhead family with important roles in reproduction. Recent studies showed that FOXL2 is expressed in human and bovine endometrium and that its levels fluctuate during pregnancy. In this study, we aimed at evaluating the expression and function of FOXL2 in embryo implantation. METHODS: Mouse uteri at different days of pregnancy were isolated and analyzed for the expression and localization of FOXL2. A lentiviral strategy was further employed to either knockdown or overexpress FOXL2 in non-receptive human endometrial AN3-CA cells and in receptive Ishikawa cells, respectively. These genetically modified cells were compared to cells infected with a control lentivirus to determine the function of FOXL2 in trophectoderm cells adherence to Endometrial Epithelium was associated with the expression of genes known to be involved in acquisition of uterine receptivity. RESULTS: We report that FOXL2 is expressed in both, the luminal epithelium and the myometrium of the mouse uterus and that its expression declines prior to implantation. We found that endometrial cells expressing low FOXL2 levels, either endogenous or genetically manipulated, were associated with a higher attachment rate of mouse blastocysts or human Jeg3 spheroids and mouse blastocysts. In accordance, low-FOXL2 levels were associated with changes in the expression level of components of the Wnt/Fzd and apoptotic pathways, both of which are involved in uterine receptivity. Furthermore, FOXL2 expression was inversely correlated with G-protein signaling protein 2 (Rgs2) and cytokine expression. CONCLUSIONS: These results suggest that FOXL2 interferes with embryo attachment. Better understanding of the function of FOXL2 in the uterus would possibly suggest novel strategies for treatment of infertility attributed to repeated implantation failure.
Subject(s)
Cell Adhesion/physiology , Embryo Implantation/physiology , Endometrium/metabolism , Forkhead Box Protein L2/metabolism , Uterus/metabolism , Animals , Cell Line, Tumor , Epithelium/metabolism , Female , Gene Expression Regulation , Humans , Mice , Pregnancy , Signal Transduction/physiologyABSTRACT
In dairy cows, heat stress depresses appetite, leading to decreased food intake, a negative energy balance, and modifies ghrelin levels. Ghrelin is a gut-brain peptide with two major forms: acylated, with an O-n-octanoylated serine in position 3, and nonacylated. To date, the effect of heat stress and estrous cycle on ghrelin secretion in dairy cows has not been studied. We characterized ghrelin secretion during the estrous cycle in each, the winter and the summer seasons. We further examined the effects of parity on ghrelin secretion. Blood was collected from 10 primiparous or multiparous Israeli-Holstein dairy cows throughout the estrous cycle, in both, the hot and cold seasons. The levels of acylated and total ghrelin were measured in the blood samples. We found that both acylated and total ghrelin levels during heat stress were lower than their respective levels in the winter in both, primiparous and multiparous cows. No differences in acylated and total ghrelin levels were found between primiparous and multiparous cows in both seasons. We further found that in multiparous but not primiparous cows acylated ghrelin secretion oscillated during the estrous cycle in both seasons. Its levels peaked on the last days of the first follicular wave and on the days before and during ovulation. Interestingly, we found that elevated acylated ghrelin levels correlated with conception success and increased total ghrelin levels were associated with successful conception from first insemination. Our data is the first to demonstrate seasonal variation in ghrelin secretion. This study provides evidence for the yet unfamiliar link between heat stress, ghrelin and fertility. Increased circulating acylated ghrelin may contribute to improved fertility in dairy cows. It further raises the possibility of a link between ghrelin levels and successful inseminations. Further research is required to determine the effects of ghrelin on dairy cow performance.
Subject(s)
Estrous Cycle/physiology , Ghrelin/pharmacology , Parity/physiology , Animals , Cattle , Female , Fertility , Heat-Shock Response , Pregnancy , SeasonsABSTRACT
The use of ultrasound imaging for the examination of reproductive organs has contributed substantially to the fertility management of dairy cows around the world. This method has many advantages such as noninvasiveness and immediate availability of information. Adding Doppler index to the ultrasound imaging examination, improved the estimation of blood volume and flow rate to the ovaries in general and to the dominant follicle in particular. The aim of this study was to examine changes in the blood flow to the dominant follicle and compare them to the follicular development throughout the cycle. We further set out to examine the effects of different types of cooling management during the summer on the changes in blood flow to the dominant follicle. For this purpose, 24 Israeli-Holstein dairy cows, under heat stress, were randomly assigned one of two groups: one was exposed to five cooling sessions per day (5CS) and the other to eight cooling sessions per day (8CS). Blood flow to the dominant follicle was measured daily using Doppler index throughout the estrous cycle. No differences in the preovulatory dominant follicle diameter were detected between the two cooling management regimens during the cycle. However, the length of the first follicular wave was significantly longer, whereas the second follicular wave was nonsignificantly shorter in the 5CS group as compared to the 8CS group. In addition, no difference in blood flow was found during the first 18 days of the cycle between the two groups. However, from Day 20 until ovulation a higher rate of blood flow was measured in the ovaries of cows cooled 8 times per day as compared to the 5CS group. No differences in progesterone levels were noted. Finally, the estrous cycle length was shorter in the 8CS group as compared to the 5CS group. Our data suggest that blood flow to the dominant follicle and estrous cycle length is affected by heat stress. Using the appropriate cooling management during heat stress can enhance the blood flow to the ovary and may contribute to improved fertility in dairy cows.
Subject(s)
Cattle/physiology , Cold Temperature , Estrous Cycle/physiology , Hot Temperature , Ovarian Follicle/physiology , Stress, Physiological , Animal Husbandry , Animals , Cattle/blood , Female , Progesterone/blood , Time FactorsABSTRACT
Oocyte quality is a well-established determinant of embryonic fate. However, the molecular participants and biological markers that affect and may predict adequate embryonic development are largely elusive. Our aim was to identify the components of the oocyte molecular machinery that part take in the production of a healthy embryo. For this purpose, we used an animal model, generated by us previously, the oocytes of which do not express Cx43 (Cx43(del/del)). In these mice, oogenesis appears normal, fertilisation does occur, early embryonic development is successful but implantation fails. We used magnetic resonance imaging analysis combined with histological examination to characterise the embryonic developmental incompetence. Reciprocal embryo transfer confirmed that the blastocyst evolved from the Cx43(del/del) oocyte is responsible for the implantation disorder. In order to unveil the genes, the impaired expression of which brings about the development of defective embryos, we carried out a genomic screening of both the oocytes and the resulting blastocysts. This microarray analysis revealed a low expression of Egr1, Rpl21 and Eif4a1 in Cx43(del/del) oocytes and downregulation of Rpl15 and Eif4g2 in the resulting blastocysts. We propose that global deficiencies in genes related to the expression of ribosomal proteins and translation initiation factors in apparently normal oocytes bring about accumulation of defects, which significantly compromise their developmental capacity. The blastocysts resulting from such oocytes, which grow within a confined space until implantation, may be unable to generate enough biological mass to allow their expansion. This information could be implicated to diagnosis and treatment of infertility, particularly to IVF.
Subject(s)
Blastocyst/metabolism , Embryo Implantation, Delayed/genetics , Gene Expression Regulation, Developmental , Oocytes/metabolism , Protein Biosynthesis/genetics , Animals , Connexin 43/deficiency , Connexin 43/genetics , Embryo Transfer , Eukaryotic Initiation Factors/deficiency , Eukaryotic Initiation Factors/genetics , Female , Genotype , Magnetic Resonance Imaging , Mice, Inbred C57BL , Mice, Knockout , Phenotype , Pregnancy , Ribosomal Proteins/deficiency , Ribosomal Proteins/geneticsABSTRACT
OBJECTIVE: Ghrelin is known to regulate appetite control and cellular metabolism. The corticotropin-releasing factor (CRF) family is also known to regulate energy balance. In this study, the links between ghrelin and the CRF family in C2C12 cells, a mouse myoblast cell line was investigated. DESIGN AND METHODS: C2C12 cells were treated with ghrelin in the presence or absence of CRF receptor antagonists and then subjected to different metabolic analyses. RESULTS: Ghrelin enhanced glucose uptake by C2C12 cells, induced GLUT4 translocation to the cell surface and decreased RBP4 expression. A CRF-R2 selective antagonist, anti-sauvagine-30, blocked ghrelin-induced glucose uptake, Ghrelin upregulated CRF-R2 but not CRF-R1 levels. Moreover, ghrelin-treated C2C12 cells displayed a cAMP and pERK activation in response to Ucn3, a CRF-R2 specific ligand, but not in response to CRF or stressin, CRF-R1 specific ligands. Ghrelin also induced UCP2 and UCP3 expression, which were blocked by anti- sauvagine-30. Ghrelin did not induce fatty acids uptake by C2C12 cells or ACC expression. Even though C2C12 cells clearly exhibited responses to ghrelin, the known ghrelin receptor, GHSR1a, was not detectable in C2C12 cells. CONCLUSION: The results suggest that, ghrelin plays a role in regulating muscle glucose and, raise the possibility that suppression of the CRF-R2 pathway might provide benefits in high ghrelin states.
Subject(s)
Gene Expression Regulation , Ghrelin/metabolism , Glucose/metabolism , Myoblasts/metabolism , Receptors, Corticotropin-Releasing Hormone/agonists , Receptors, Ghrelin/metabolism , Signal Transduction , Animals , Antibodies, Blocking/pharmacology , Biological Transport/drug effects , Cell Line , Cell Membrane/drug effects , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Gene Expression Regulation/drug effects , Glucose Transporter Type 4/metabolism , Ion Channels/agonists , Ion Channels/genetics , Ion Channels/metabolism , Mice , Mitochondrial Proteins/agonists , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Myoblasts/drug effects , Myoblasts/ultrastructure , Protein Transport/drug effects , Pyrimidines/pharmacology , Pyrroles/pharmacology , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors , Receptors, Corticotropin-Releasing Hormone/genetics , Receptors, Corticotropin-Releasing Hormone/metabolism , Receptors, Ghrelin/genetics , Retinol-Binding Proteins, Plasma/antagonists & inhibitors , Retinol-Binding Proteins, Plasma/genetics , Retinol-Binding Proteins, Plasma/metabolism , Signal Transduction/drug effects , Uncoupling Protein 2 , Uncoupling Protein 3 , Urocortins/metabolismABSTRACT
Administration of synthetic or purified peptides directly into the brain ventricles is a method commonly used by neuroscientists for exploring physiological and behavioral functions of gene products. i.v. administration is controlled by the blood-brain barrier, which limits its effectiveness, and current approaches for acute or chronic intracerebroventricular delivery have significant technical drawbacks resulting from both the chemical properties of the delivered substance and the experimental procedures. Here we describe a genetic approach for the delivery of secreted peptides or proteins into the cerebrospinal fluid (CSF). Using a choroid plexus-specific promoter, we established a lentiviral-based system, which offers inducible and reversible delivery of a gene product into the CSF. The functionality of this system was demonstrated by using the overexpression of the two established neuropeptides, corticotropin-releasing factor and gonadotropin-releasing hormone, modulating anxiety-like behavior and estrus cycle, respectively. We show that this choroid plexus-specific lentiviral-based system is a reliable, effective, and adaptable research tool for intracerebroventricular delivery.
Subject(s)
Genetic Vectors , Injections, Intraventricular , Lentivirus/genetics , Peptides/administration & dosage , Animals , Cell Line , Humans , Immunohistochemistry , In Situ Hybridization , MiceABSTRACT
We have recently demonstrated that the rat ovary expresses LHbeta, FSHbeta, and the common alpha subunit mRNA. In the present report, we studied the regulation of LHbeta and of gonadotropin-releasing hormone (GnRH) mRNA expression in granulosa cells that were isolated from immature rats treated with either estrogen or pregnant mare serum gonadotropin (PMSG). In both cell types, GnRH agonist treatment resulted in a decrease in LHbeta mRNA expression. However, only in cells derived from PMSG-treated rats, GnRH treatment produced an increase in GnRH mRNA expression. A markedly increased GnRH mRNA expression was also obtained in granulosa cells derived from PMSG-primed rats in response to LH. In addition, FSH reduced the expression of LHbeta mRNA in granulosa cells from estrogen-primed rats. These results suggest that the expression of LHbeta in the ovary is regulated by locally produced GnRH and by FSH from either the ovary or the pituitary.
Subject(s)
Gene Expression Regulation , Gonadotropin-Releasing Hormone , Granulosa Cells/physiology , Luteinizing Hormone, beta Subunit , RNA, Messenger , Animals , Female , Follicle Stimulating Hormone/metabolism , Gonadotropin-Releasing Hormone/agonists , Gonadotropin-Releasing Hormone/genetics , Gonadotropin-Releasing Hormone/metabolism , Granulosa Cells/cytology , Horses , Humans , Luteinizing Hormone, beta Subunit/genetics , Luteinizing Hormone, beta Subunit/metabolism , Ovary/cytology , Ovary/metabolism , Pregnancy , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , SheepABSTRACT
The gonadotropic hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are synthesized by and released from the anterior pituitary in response to the hypothalamic gonadotropin-releasing hormone (GnRH) signaling. In the female, LH and FSH affect folliculogenesis, ovarian steroid production, oocyte maturation, ovulation and corpus luteum formation. We have recently studied the expression of GnRH and its receptor in the rat ovary and found organ-specific, estrous cycle-dependant, fluctuations. Subsequently, we wished to determine whether rat ovaries also express gonadotropic hormones. Using RT-PCR, we detected LHbeta, FSHbeta and the common alpha-subunit mRNA's in intact follicles, theca cells, corpora lutea and in meiotically competent and incompetent oocytes. Granulosa cells, however, express mRNA's for LHbeta and the common alpha-subunit, but not for FSHbeta. We cloned and sequenced the ovarian LHbeta transcript and found it to be longer (2.3kb) than the one produced by pituitary gonadotropes (0.8kb), due to a longer 5'-UTR. We studied the regulation of ovarian LHbeta mRNA in sexually immature female rats administered with pregnant mare serum gonadotropin (PMSG) and in adult cyclic rats. PMSG administration caused a significant decrease in LHbeta mRNA expression, detected by real-time PCR. Similarly, LHbeta mRNA levels were lower on estrous morning versus proestrous evening. Interestingly, ovarian content of LH remained unchanged following hypophysectomy, although ovarian weight was immensely reduced. Taken together, it seems probable that ovarian LH is heterologously/homologously regulated by pituitary, and possibly also by local gonadotropins. Thus, these findings may imply the existence of a local GnRH-gonadotropin axis in the mammalian ovary that may be involved in the management of processes that lead to ovulation.
Subject(s)
Follicle Stimulating Hormone, beta Subunit/metabolism , Glycoprotein Hormones, alpha Subunit/metabolism , Luteinizing Hormone, beta Subunit/metabolism , Ovary/metabolism , Animals , Female , Gonadotropins, Equine/pharmacology , Granulosa Cells/cytology , Granulosa Cells/metabolism , Luteinizing Hormone/metabolism , Oocytes/cytology , Oocytes/drug effects , Oocytes/metabolism , Ovary/cytology , Ovary/drug effects , Ovulation/physiology , RNA, Messenger/metabolism , Rats , Rats, Wistar , Theca Cells/cytology , Theca Cells/metabolismABSTRACT
Gap junctions, predominantly comprising connexin43 (Cx43), mediate cell-to-cell communication within the ovarian follicle. However, the partaking of Cx43 in the formation of the gap junction channels, between the oocyte and the somatic cells, is controversial. We addressed this dispute by crossing females that carry a Cx43 coding region, flanked by loxP recognition sites, with males expressing the Cre recombinase under the control of Zp3 promoter. Oocytes of the resultant Zp3Cre;Gja1(lox/lox) mice did not express Cx43 and were referred to as Cx43(del/del). Unexpectedly, a decrease in Cx43 was observed in cumulus/granulosa cells of some follicles as well. Nevertheless, no histological abnormalities were detected in the ovaries of the Zp3Cre;Gja1(lox/lox) mice. Furthermore, these mice ovulated normally and developed fully functional corpora lutea. Additionally, the ovarian Cx43(del/del) oocytes were meiotically arrested and transferred Lucifer yellow to the surrounding cumulus cells. However, mating Zp3Cre;Gja1(lox/lox) females with wild-type males resulted in a reduced rate of parturition and a substantial decrease in litter size. Further examination revealed that although preimplantation development of Zp3Cre;Gja1(lox/+) embryos was normal, the blactocysts exhibited impaired implantation. Our data suggest that total ablation of Cx43 in the oocyte, combined with its decrease in the surrounding somatic cells, allows normal oogenesis and folliculogenesis, ovulation and early embryonic development but severely impairs the implantation capacity of the resulting blactocysts.
Subject(s)
Connexin 43/metabolism , Infertility , Oocytes/metabolism , Animals , Embryo Implantation , Embryo, Mammalian/metabolism , Female , Gap Junctions/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, TransgenicABSTRACT
Gap junctions that allow the direct communication between cytoplasmic compartments of neighboring cells are present in a variety of tissues and organs and play pivotal roles in a wide range of physiological processes. In the ovary, gap junctions consist mainly of connexin (Cx) 43 and Cx37, and their indispensable role in regulating folliculogenesis and oogenesis is well established. The ovarian Cx43 is regulated by gonadotropins at the transcriptional, translational and post-translational levels whereas the regulation of the ovarian Cx37 is yet unknown. In addition to their involvement in normal ovarian functions, gap junction proteins, particularly Cx43, seem to act as cancer suppressors. A summary of our present knowledge regarding gap junctional communication (GJC) and the ovarian gap junction proteins in normally developing ovaries and under pathological conditions is presented in this review.
Subject(s)
Gap Junctions/metabolism , Ovary/metabolism , Animals , Cattle , Cell Communication , Connexin 43/metabolism , Connexins/metabolism , Female , Humans , Mice , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Ovary/cytology , Rats , Sheep , Swine , Gap Junction alpha-4 ProteinABSTRACT
The SULT1E1-encoded estrogen sulfotransferase (EST) catalyzes sulfation of estrogen, resulting in its inactivation. Reduced fertility observed in SULT1E1 knockout (KO) female mice has previously been attributed to the deleterious effect of chronic exposure to high levels of circulating estrogen on placental function. We herein suggest that, in addition to placental dysfunction, this phenotype demonstrates that an excess of estrogen impairs ovulation. The role of SULT1E1 in ovulation is suggested by the substantially low ovulatory response in hCG-treated SULT1E1 KO mice; a similar effect was observed when 17beta-estradiol was administered to wild-type (WT) females. The normal rate of ovulation in SULT1E1 KO females may be restored by PGE2. Along this line, ovaries of human Chorionic Gonadotropin (hCG)-treated SULT1E1 KO mice expressed low levels of cyclooxygenase-2 (COX-2) and its downstream TSG6; moreover, their ovaries contained a reduced number of expanded cumuli. Our results demonstrate, for the first time, that estrogen inactivation may allow the expression of COX-2 and subsequent cumulus expansion, enabling normal ovulation. Our findings may be applied to novel treatments of human ovulatory failure.
Subject(s)
Cyclooxygenase 2/genetics , Ovary/pathology , Sulfotransferases/physiology , Animals , Chorionic Gonadotropin/administration & dosage , Chorionic Gonadotropin/pharmacology , Dinoprostone/administration & dosage , Dinoprostone/pharmacology , Female , Humans , Infertility/drug therapy , Mice , Mice, Knockout , Ovary/drug effects , Ovulation/drug effects , Sulfotransferases/deficiencyABSTRACT
Resumption of meiosis in oocytes represents the entry into M-phase of the cell cycle and is regulated by the maturation-promoting factor (MPF). Activation of MPF is catalyzed by the dual specificity phosphatase, cdc25. In mammals, cdc25 is represented by a multigene family consisting of three isoforms: A, B and C. A recent report that female mice lacking cdc25B exhibit impaired fertility suggests a role for this isoform in regulating the G2- to M-transition in mammalian oocytes. Supporting the above-mentioned observation, we demonstrate herein that microinjection of neutralizing antibodies against cdc25B interfered with the ability of rat oocytes to undergo germinal vesicle breakdown (GVB). We also show accumulation of cdc25B in GVB oocytes and a transient reduction in its amount at metaphase I of meiosis. The accumulation of cdc25B was associated with its mRNA cytoplasmatic polyadenylation and was prevented by the protein synthesis inhibitor cyclohexamide as well as by the polyadenylation inhibitor cordycepin. Immunofluorescence staining revealed translocation of cdc25B to the metaphase II spindle apparatus. Taken together, our findings provide evidence that cdc25B is involved in resumption of meiosis in rat oocytes. We further demonstrate for the first time, a periodic accumulation of cdc25B throughout meiosis that is translationally regulated and involves cdc25B mRNA polyadenylation.
Subject(s)
Cytoplasm/metabolism , Meiosis , Oocytes/metabolism , Protein Biosynthesis , Animals , Antibodies, Monoclonal/pharmacology , Biological Transport , Blotting, Western/methods , Cell Cycle Proteins/genetics , Cell Cycle Proteins/immunology , Cell Cycle Proteins/metabolism , Cells, Cultured , Cycloheximide/pharmacology , Deoxyadenosines/pharmacology , Female , Fluorescent Antibody Technique , Immunohistochemistry/methods , Maturation-Promoting Factor/metabolism , Mesothelin , Microinjections , Polyadenylation/drug effects , Protein Synthesis Inhibitors/pharmacology , Rats , Rats, Wistar , Spindle Apparatus/metabolism , cdc25 Phosphatases/genetics , cdc25 Phosphatases/immunology , cdc25 Phosphatases/metabolismABSTRACT
Cyclic adenosine monophosphate (cAMP) keeps oocytes in meiotic arrest, thereby preventing activation of the key regulators of meiosis, p34cdc2/cyclin B1, (known as maturation-promoting factor (MPF)) and Erk 1 and 2, members of the mitogen-activated protein kinase (MAPK) family. The activity of MAPK in oocytes is upregulated by Mos. We previously demonstrated that Mos translation in rat oocytes is negatively regulated by a PKA-mediated cAMP action, which inhibits c-mos mRNA polyadenylation and is associated with the suppression of p34 cdc2 kinase. The goal of the present study was to provide definitive evidence that Mos translation is subjected to MPF regulation. In order to inhibit MPF activity, we employed the double-stranded (ds) RNA interference (RNAi) of gene expression. We demonstrated that the introduction of cyclin B1 dsRNA into rat oocytes selectively depleted the corresponding mRNA, further ablating its protein product. These oocytes, which exhibit low MPF activity, failed to elongate the c-mos mRNA poly(A) tail, did not accumulate Mos and were unable to activate MAPK. We conclude that an active MPF in rat oocytes is necessary for c-mos mRNA polyadenylation and Mos translation.